Chip Sector M&A, The Markets On Stimulus Watch and COVID-19 Treatment Developments
b'Carl Quintanilla, Jim Cramer and David Faber discussed the big corporate story of the day: Chipmaker AMD reportedly in advance talks to buy Xilinx in a deal that could be worth more than $30-billion. The anchors explored what such a transaction could mean for the semiconductor sector and where China fits into the mix. Markets also paying close attention to Speaker Pelosi, Treasury Secretary Mnuchin and the state of stimulus talks -- with Senate Majority Leader Mitch McConnell saying another coronavirus aid package is needed. Also on the COVID-19 front: Carl, David and Jim weighed in on comments by the CEO of Gilead Sciences, which released final data from a study of its remdesivir anti-viral treatment. The study showed that the drug cut recovery time by five days compared to patients who received a placebo.'